c diagnosis of heart disease has resulted from the developmellt and widespread appli-('atioll of methods to quantitate levels of enzv-ine activities in the blood or serum of man.
C.COOH + NH2*CH*COOH Such a transainination had beeni demonstrated in model, nonenzymatic reactions.
Braunstein and Kritzmann6 first demonstrated the presence of enzymes catalyzing such reactionis in pigeon breast and rabbit musele. Subsequent studies have revealed that trainsamination is probably the most important metabolic mechanism in both the formation and deamination of many amino acids in various tissues. There are two separable major tranisaminating enzymes in heart muscle:
A. The glutamic-oxala(ceti( tranisaminiase (GOT), which catalyzes the reaction 1-Glutamnic acid + oxalacetic acid A-SYMPOSIUM ON CORONARY HEART DISEASE postulated that the pyridoxal phosphate first reacts with the amino acid to form a keto-acid and pyridoxamine phosphate, which then donates the amino group to another keto-acid, thus effecting the ultimate transamination.
In consonance with this view, B6 deficiency results in lowered levels of transaminase activity.
Methods of Measurement
It is essential to note that, at the present stage of development, the available methods of enzymology measure rates of reactions, i.e., they reflect over-all levels of activity and not the actual concentration of a specific enzyme molecule. The manifold complexities of serum with its possible inhibitors, precursors, activators, complex formation, etc., necessitate this mental reservation and remind us of the completely empirical status of current methods. Furthermore, some confusion has resulted from the early multiplicity of methods with the resultant differences in "normal" and ''abnormal values, necessitating critical evaluation of the specific methods employed in the reporting laboratory.
GOT and GPT are the two major transaminases of clinical import. When their activities are measured in serum, the appropriate terms in current usage are SGOT and SGPT (serum glutamic-oxalacetic and serum glutamic-pyruvic transaminase, respectively). Enzyme activity is strikingly constant in health, remaining essentially unaltered by ingestion of food, exercise, or storage at room temperature for 24 hours or at 0 to 5 C. for 2 weeks.
Clinicopathologic Correlations
Under normal conditions the abundant transaminases are confined, almost exclusively, within tissue cells and only very small amounts are found in the circulation. It is this relatively small "baseline" serum level which first suggested and has permitted ready detection of increased serum values resulting from destruction of tissue and the assumed release of enzyme from the large tissue stores. For example, dog heart tissue contains 300,to 48 hours and returning to normal range by the fourth to seventh day. In certain cases, however, an elevation was not detected until 36 hours after the onset of symptoms and return to normal occurred as soon as 48 hours.
These clinical findings have been strongly supported by experimental studies of myocardial damage by several workers using various technics, revealing excellent correlations of increased serum levels of enzyme activity with tissue damage. Significant elevations of SGOT, although short-lived, have been found with experimentally induced infarcts of less than 1 Gm. of myocardium. There was a suggestive correlation between the size of the infarct and the height and duration of increased serum enzyme activity. Enzyme levels decreased rapidly in infarcted muscle as compared to normal muscle. In almost every instance, serum enzyme levels were not increased in the presence of significant myocardial ischemia without histologic necrosis. Similarly, experimental pulmonary infarction or pericarditis in dogs usually resulted in no increase in SGOT or SGPT.
In man, with the obvious limitations of precise definitions, a generally rough correlation of extent of damaged tissue and increase of enzyme activity has been suggested. Although a peak rise above 300 units has generally indicated a poor prognosis, frequent exceptions at both extremes (recovery in patients with extremely high levels, death in patients with only slight increases) render the actual level of little prognostic value in a given case.
SGPT is -'frequently normal in the'. face of elevated SGOT in the less extensive' infarctions, but may rise in the presence of large infarcts. Although it has been stated that SGPT is not Thus, as with all laboratory tests, considered clinical judgment of the over-all picture ro-mains essential. Despite this limitation, demonstration of elevated serum levels of certain enzymes (the two most useful at this time being SGOT and LDH) serves, in the proper clinical setting, as a highly valuable indicator of myocardial necrosis; failure to observe this on serial testing is an important negative finding. The SGOT activity rises promptly after myocardial infarction, permitting early confirmation. LDH, simpler to measure, affords the advantage of a more persisting abnormality (up to 10 to 14 days after infarction). In most comparative studies, LDII measurements appear to afford a greater over-all positive correlation with the ultimate diagnosis. The rapid development of this area of knowledge has already increased the diagnostic armamentarium of the clinician. Recent promise of methods to increase the specificity of the results augurs well for the future.
